MIRA Pharmaceuticals, Inc. (MIRA)

Price & Market Data

Price: $0.992

Daily Change: +$0.0039 / 0.39%

Daily Range: $0.979 - $1.00

Market Cap: $41,685,912

Daily Volume: 33,275

Performance Metrics

1 Week: 2.29%

1 Month: -11.25%

3 Months: -17.22%

6 Months: -25.93%

1 Year: -17.22%

YTD: -33.44%

About MIRA Pharmaceuticals, Inc. (MIRA)

A complete market overview for MIRA Pharmaceuticals, Inc. (MIRA). The stock is at 0.992, with a daily change of +$0.0039 / 0.39%. Market cap: 41,685,912. Delve into its YTD and 3-month performance.

Company Details

Employees: 2

Sector: Health technology

Industry: Pharmaceuticals: other

Country: United States

Details

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial. It also offers oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia; and SKNY-1, that is in preclinical stage for obesity and nicotine dependence. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.

Selected stocks

Caribou Biosciences, Inc. (CRBU)

Annexon, Inc. (ANNX)

ZOOZ Strategy Ltd. (ZOOZ)

Black Diamond Therapeutics, Inc. (BDTX)

NOVONIX Limited - American Depository Shares (NVX)